-+ 0.00%
-+ 0.00%
-+ 0.00%
Kei Pharma (4896) 3Q operating loss widens (▲7.65 billion yen for non-consolidated 1-9 months), forecasted at ▲10.93 billion yen for 2026/12.
Share

Please log in to view news

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending